CN1113790A - Anti-cancer Chinese drug-Xiaoliujing capsule - Google Patents
Anti-cancer Chinese drug-Xiaoliujing capsule Download PDFInfo
- Publication number
- CN1113790A CN1113790A CN94110281A CN94110281A CN1113790A CN 1113790 A CN1113790 A CN 1113790A CN 94110281 A CN94110281 A CN 94110281A CN 94110281 A CN94110281 A CN 94110281A CN 1113790 A CN1113790 A CN 1113790A
- Authority
- CN
- China
- Prior art keywords
- fry
- vinegar
- radix
- give birth
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The present invention relates to an anticancer Chinese drug-Xiaoliujing capsule. Its Chinese medicine composition consists of root of American ginseng, leech, corydalis tuber, notoginseng, Chinese angelica root, prepared rhizome of Curcuma aromatica, root of Chinese Stellaria, herb of Blushred Rabdosia, frankincense, myrrh, toad venom, pilose deer horn, flavescent sophora root, coptis root, batryticated silkworm and Chinese caterpillar fungus. The above-mentioned Chinese medicines are pulverized, uniformly mixed, screened by sieve number zero three times, and then aseptically placed in capsule number zero. Said invention is easy to take, long in storage period and obvious in anticancer result.
Description
The present invention relates to a kind of Chinese medicine preparation, particularly a kind of anticancer Chinese medicinal capsule preparation.
Existing Chinese medicine medicine for preventing preparation has decoction, powder etc., takes very inconveniently, and effect is also not really desirable, for decoction, can destroy active ingredient when boiling, and after being boiled into, storage period is short, boils trouble, bitter in the mouth, and amount is big, is difficult for accepting.
The objective of the invention is in order to overcome above-mentioned deficiency, it is good to propose a kind of therapeutic effect, the anticancer capsule preparation of taking convenience.
The present invention is achieved using the following method.
The Chinese medicine composition and the content of Xiaoliujing capsule are as follows:
Radix Panacis Quinquefolii 217-237g Hirudo (Pulvis Talci scalds) 126-146g
Rhizoma Corydalis (vinegar stir-fry) 217-237g Radix Notoginseng (give birth to and use) 126-146g
Radix Angelicae Sinensis (giving birth to) 217-237g temperature Rhizoma Curcumae (vinegar stir-fry) 217-237g with section
Stellera chamaejasme L. (vinegar system) 85-105g Rabdosia rubescens (aerial parts) 217-237g
Olibanum (vinegar stir-fry) 81-101g Myrrha (vinegar stir-fry) 81-101g
Venenum Bufonis (processed with wine) 126-146g Cornu Cervi Pantotrichum (two thick stick first-class) 217-237g
Radix Sophorae Flavescentis (give birth to and use tablet) 217-237g Rhizoma Coptidis (processed with Rhizoma Zingiberis Recens) 217-237g
Bombyx Batryticatus (parched with bran) 262-282g Cordyceps (give birth to and use) 217-237g
The Chinese medicine of above-mentioned composition and content, processing powder is broken into fine powder, and mix homogeneously is crossed No. 6 and sieved three times, under aseptic condition, incapsulates.
Prove that through pharmacological testing the present invention is to white mice transplanted tumor S
180With the EAC solid type obvious antitumor action is arranged all, test has better repeatability and dose-effect relationship, to S
180Three batches of average suppression ratio of high and low two dosage groups be respectively 66.8% and 45.9%(P＜0.01); To three batches of average suppression ratio of EAC entity, high dose is 52.2%(P＜0.01), low dosage is 44.9%(P＜0.01), all, illustrate that the present invention is to S above effective standard of 30%
180With the EAC solid type stronger antitumor action is arranged all.
Chinese medicine preparation of the present invention, taking convenience, storage period are long, do not have toxic and side effects.
Embodiment:
Radix Panacis Quinquefolii 227g Hirudo (Pulvis Talci scalds) 136g
Rhizoma Corydalis (vinegar stir-fry) 227g Radix Notoginseng (give birth to and use) 136g
Radix Angelicae Sinensis (giving birth to) 227g temperature Rhizoma Curcumae (vinegar stir-fry) 227g with section
Stellera chamaejasme L. (vinegar system) 95g Rabdosia rubescens (aerial parts) 227g
Olibanum (vinegar stir-fry) 91g Myrrha (vinegar stir-fry) 91g
Venenum Bufonis (processed with wine) 136g Cornu Cervi Pantotrichum (two thick stick first-class) 227g
Radix Sophorae Flavescentis (give birth to and use tablet) 227g Rhizoma Coptidis (processed with Rhizoma Zingiberis Recens) 227g
Bombyx Batryticatus (parched with bran) 272g Cordyceps (give birth to and use) 227g
Method for making: it is an amount of to get Cornu Cervi Pantotrichum, burns remove floss, and scraping is split into fragment, is ground into fine powder, take by weighing 227 the gram standby.In addition with an amount of Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) and Venenum Bufonis, processing powder is broken into fine powder respectively, and it is standby to take by weighing recipe quantity.Take by weighing other medical material of respectively distinguishing the flavor of of above-mentioned recipe quantity after the processing and mix and pulverize, add Pulveratum Cornu Cervi Pantotrichum, Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) powder, Venenum Bufonis powder, mix homogeneously is crossed No. 6 sieves three times.Under aseptic condition, adorn 10,000 of No. 0 capsules.
Claims (2)
1, a kind of Chinese medicine medicine for preventing Xiaoliujing capsule adopts medicament in the capsulation powdery, and it is characterized in that: the composition and the content of the middle medicament of 10,000 capsules are:
Radix Panacis Quinquefolii 217-237g Hirudo (Pulvis Talci scalds) 126-146g
Rhizoma Corydalis (vinegar stir-fry) 217-237g Radix Notoginseng (give birth to and use) 126-146g
Radix Angelicae Sinensis (giving birth to) 217-237g temperature Rhizoma Curcumae (vinegar stir-fry) 217-237g with section
Stellera chamaejasme L. (vinegar system) 85-105g Rabdosia rubescens (aerial parts) 217-237g
Olibanum (vinegar stir-fry) 81-101g Myrrha (vinegar stir-fry) 81-101g
Venenum Bufonis (processed with wine) 126-146g Cornu Cervi Pantotrichum (two thick stick first-class) 217-237g
Radix Sophorae Flavescentis (give birth to and use tablet) 217-237g Rhizoma Coptidis (processed with Rhizoma Zingiberis Recens) 217-237g
Bombyx Batryticatus (parched with bran) 262-282g Cordyceps (give birth to and use) 217-237g
2, by the described Xiaoliujing capsule of claim 1, it is characterized in that: the composition and the content of medicament are in described:
Radix Panacis Quinquefolii 227g Hirudo (Pulvis Talci scalds) 136g
Rhizoma Corydalis (vinegar stir-fry) 227g Radix Notoginseng (give birth to and use) 136g
Radix Angelicae Sinensis (giving birth to) 227g temperature Rhizoma Curcumae (vinegar stir-fry) 227g with section
Stellera chamaejasme L. (vinegar system) 95g Rabdosia rubescens (aerial parts) 227g
Olibanum (vinegar stir-fry) 91g Myrrha (vinegar stir-fry) 91g
Venenum Bufonis (processed with wine) 136g Cornu Cervi Pantotrichum (two thick stick first-class) 227g
Radix Sophorae Flavescentis (give birth to and use tablet) 227g Rhizoma Coptidis (processed with Rhizoma Zingiberis Recens) 227g
Bombyx Batryticatus (parched with bran) 272g Cordyceps (give birth to and use) 227g
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94110281A CN1051926C (en) | 1994-05-27 | 1994-05-27 | Anti-cancer Chinese drug-Xiaoliujing capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94110281A CN1051926C (en) | 1994-05-27 | 1994-05-27 | Anti-cancer Chinese drug-Xiaoliujing capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1113790A true CN1113790A (en) | 1995-12-27 |
| CN1051926C CN1051926C (en) | 2000-05-03 |
Family
ID=5034261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94110281A Expired - Fee Related CN1051926C (en) | 1994-05-27 | 1994-05-27 | Anti-cancer Chinese drug-Xiaoliujing capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1051926C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999022749A1 (en) * | 1997-11-05 | 1999-05-14 | Sam Chun Dang Pharm Co., Ltd. | Galenic preparation for prevention and treatment of hepatocarcinoma |
| CN101450145B (en) * | 2008-12-23 | 2010-12-15 | 朱友文 | Traditional Chinese medicine for treating malignancy and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1057399A (en) * | 1990-06-18 | 1992-01-01 | 李文升 | A kind of manufacture method of Chinese medicine atomic powder for clearing lump in abdomen |
| CN1085093A (en) * | 1993-06-14 | 1994-04-13 | 沈庆新 | The prescription of cancer eliminating pill and production technology |
-
1994
- 1994-05-27 CN CN94110281A patent/CN1051926C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999022749A1 (en) * | 1997-11-05 | 1999-05-14 | Sam Chun Dang Pharm Co., Ltd. | Galenic preparation for prevention and treatment of hepatocarcinoma |
| CN101450145B (en) * | 2008-12-23 | 2010-12-15 | 朱友文 | Traditional Chinese medicine for treating malignancy and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1051926C (en) | 2000-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006060951A1 (en) | A pharmaceutical composition for the treatment and/or prevention of hyperlipidemia, processes for producing the same and the use thereof | |
| CN1224614A (en) | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation | |
| KR20040012447A (en) | Herbal pharmaceutical composition for treatment of hiv/aids patients | |
| CN105535448B (en) | Traditional Chinese medicine composition for treating children myasthenia gravis | |
| CN1051008C (en) | Chinese medicine composite for coronary heart disease and angina | |
| CN101732395B (en) | Medicine or health-care food composition with function of regulating immunity, preparation method and application thereof | |
| CN1113790A (en) | Anti-cancer Chinese drug-Xiaoliujing capsule | |
| CN1274592A (en) | Enterogastric disease treating medicine and its preparation | |
| CN1160560A (en) | Chinese patent drug for curing leukopenia and its preparation process | |
| CN1044565C (en) | Quick-acting fat-lowering traditional Chinese medicine | |
| CN1227019C (en) | Chinese medicine prepn for preventing fibrillated liver and treating hepatocirrhosis | |
| CN1736449A (en) | Powder for climacteric syndrome and its preparing process | |
| CN101822760A (en) | Anti-senile dementia traditional Chinese medicine composite preparation and preparation process thereof | |
| CN1698708A (en) | Leucorrhea disease treatment capsule and its preparation method | |
| CN1052639C (en) | Traditional Chinese medicine capsule for treating rheumatoid arthritis | |
| CN112914009A (en) | Health-care solid beverage for yang-deficiency constitution and preparation method thereof | |
| CN1234408C (en) | Compound Sanhuang powder | |
| CN1895630A (en) | Chinese medicine for treating apoplexia hemiparalysis, chestache and cardiodynia and its preparation | |
| CN115969903B (en) | Traditional Chinese medicine composition, preparation method thereof and application of traditional Chinese medicine composition in preparation of medicines with fatty liver prevention and treatment effects | |
| CN1060663C (en) | Compound Tibet capillary artemisia patent medicine | |
| CN88100048A (en) | The production method of Chinese patent medicine AIDS spirit (AIDSLIUM) preparation | |
| CN1107350A (en) | "Changhualing" No.1 for treatment of colitis and its preparing process | |
| CN1056759C (en) | Traditional Chinese medicine preparation for prevention and treatment of hepatitis B | |
| CN1108943A (en) | Medicine "Yigankang" for hepatitis B and its preparation | |
| CN101700323B (en) | Pharmaceutical composition for preventing and treating liver cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |